▶ 調査レポート

化膿性汗腺炎治療の世界市場 2020年：企業別、地域別、種類・用途別
• 英文タイトル：Global Hidradenitis Suppurativa Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。化膿性汗腺炎治療の世界市場 2020年：企業別、地域別、種類・用途別 / Global Hidradenitis Suppurativa Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D005-00477資料のイメージです。• レポートコード：D005-00477
• 出版社/出版日：GlobalInfoResearch / 2020年5月29日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール
• 産業分類：医療・製薬
• 販売価格（消費税別）
  Single User￥522,000 (USD3,480)▷ お問い合わせ
  Multi User￥783,000 (USD5,220)▷ お問い合わせ
  Corporate User￥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートでは、化膿性汗腺炎治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。化膿性汗腺炎治療の種類別市場規模（薬、手術、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Pfizer、Johnson & Johnson、AstraZeneca、Merck、Allergan、AbbVie
・地域別グローバル市場分析 2015年-2020年
・化膿性汗腺炎治療の北米市場（アメリカ、カナダ、メキシコ）
・化膿性汗腺炎治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）
・化膿性汗腺炎治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）
・化膿性汗腺炎治療の南米市場（ブラジル、アルゼンチン）
・化膿性汗腺炎治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ）
・種類別分析：薬、手術、その他
・用途別分析：病院、クリニック、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Hidradenitis Suppurativa Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Hidradenitis Suppurativa Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Hidradenitis Suppurativa Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Hidradenitis Suppurativa Treatment market has been segmented into:
Medications
Surgery
Others

By Application, Hidradenitis Suppurativa Treatment has been segmented into:
Hospitals
Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hidradenitis Suppurativa Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Hidradenitis Suppurativa Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hidradenitis Suppurativa Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Hidradenitis Suppurativa Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Hidradenitis Suppurativa Treatment Market Share Analysis
Hidradenitis Suppurativa Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hidradenitis Suppurativa Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hidradenitis Suppurativa Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Hidradenitis Suppurativa Treatment are:
GlaxoSmithKline
Pfizer
Johnson & Johnson
AstraZeneca
Merck
Allergan
AbbVie

レポート目次

Table of Contents

1 Hidradenitis Suppurativa Treatment Market Overview
1.1 Product Overview and Scope of Hidradenitis Suppurativa Treatment
1.2 Classification of Hidradenitis Suppurativa Treatment by Type
1.2.1 Global Hidradenitis Suppurativa Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hidradenitis Suppurativa Treatment Revenue Market Share by Type in 2019
1.2.3 Medications
1.2.4 Surgery
1.2.5 Others
1.3 Global Hidradenitis Suppurativa Treatment Market by Application
1.3.1 Overview: Global Hidradenitis Suppurativa Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Hidradenitis Suppurativa Treatment Market by Regions
1.4.1 Global Hidradenitis Suppurativa Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hidradenitis Suppurativa Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hidradenitis Suppurativa Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hidradenitis Suppurativa Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hidradenitis Suppurativa Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hidradenitis Suppurativa Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hidradenitis Suppurativa Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Allergan SWOT Analysis
2.6.4 Allergan Product and Services
2.6.5 Allergan Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AbbVie SWOT Analysis
2.7.4 AbbVie Product and Services
2.7.5 AbbVie Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hidradenitis Suppurativa Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hidradenitis Suppurativa Treatment Players Market Share
3.2.2 Top 10 Hidradenitis Suppurativa Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hidradenitis Suppurativa Treatment Revenue and Market Share by Regions
4.2 North America Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
5 North America Hidradenitis Suppurativa Treatment Revenue by Countries
5.1 North America Hidradenitis Suppurativa Treatment Revenue by Countries (2015-2020)
5.2 USA Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
6 Europe Hidradenitis Suppurativa Treatment Revenue by Countries
6.1 Europe Hidradenitis Suppurativa Treatment Revenue by Countries (2015-2020)
6.2 Germany Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
6.4 France Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hidradenitis Suppurativa Treatment Revenue by Countries
7.1 Asia-Pacific Hidradenitis Suppurativa Treatment Revenue by Countries (2015-2020)
7.2 China Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
7.5 India Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
8 South America Hidradenitis Suppurativa Treatment Revenue by Countries
8.1 South America Hidradenitis Suppurativa Treatment Revenue by Countries (2015-2020)
8.2 Brazil Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hidradenitis Suppurativa Treatment by Countries
9.1 Middle East & Africa Hidradenitis Suppurativa Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hidradenitis Suppurativa Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Hidradenitis Suppurativa Treatment Market Forecast by Type (2019-2024)
10.3 Medications Revenue Growth Rate (2015-2025)
10.4 Surgery Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Hidradenitis Suppurativa Treatment Market Segment by Application
11.1 Global Hidradenitis Suppurativa Treatment Revenue Market Share by Application (2015-2020)
11.2 Hidradenitis Suppurativa Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Hidradenitis Suppurativa Treatment Market Size Forecast (2021-2025)
12.1 Global Hidradenitis Suppurativa Treatment Market Size Forecast (2021-2025)
12.2 Global Hidradenitis Suppurativa Treatment Market Forecast by Regions (2021-2025)
12.3 North America Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
12.6 South America Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Hidradenitis Suppurativa Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hidradenitis Suppurativa Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hidradenitis Suppurativa Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hidradenitis Suppurativa Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Hidradenitis Suppurativa Treatment Major Business
Table 7. GlaxoSmithKline Hidradenitis Suppurativa Treatment Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Hidradenitis Suppurativa Treatment Product and Solutions
Table 10. GlaxoSmithKline Hidradenitis Suppurativa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Corporate Information, Location and Competitors
Table 12. Pfizer Hidradenitis Suppurativa Treatment Major Business
Table 13. Pfizer Hidradenitis Suppurativa Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer SWOT Analysis
Table 15. Pfizer Hidradenitis Suppurativa Treatment Product and Solutions
Table 16. Pfizer Hidradenitis Suppurativa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Hidradenitis Suppurativa Treatment Major Business
Table 19. Johnson & Johnson Hidradenitis Suppurativa Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Hidradenitis Suppurativa Treatment Product and Solutions
Table 22. Johnson & Johnson Hidradenitis Suppurativa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AstraZeneca Corporate Information, Location and Competitors
Table 24. AstraZeneca Hidradenitis Suppurativa Treatment Major Business
Table 25. AstraZeneca Hidradenitis Suppurativa Treatment Total Revenue (USD Million) (2017-2018)
Table 26. AstraZeneca SWOT Analysis
Table 27. AstraZeneca Hidradenitis Suppurativa Treatment Product and Solutions
Table 28. AstraZeneca Hidradenitis Suppurativa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Hidradenitis Suppurativa Treatment Major Business
Table 31. Merck Hidradenitis Suppurativa Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Hidradenitis Suppurativa Treatment Product and Solutions
Table 34. Merck Hidradenitis Suppurativa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Allergan Corporate Information, Location and Competitors
Table 36. Allergan Hidradenitis Suppurativa Treatment Major Business
Table 37. Allergan Hidradenitis Suppurativa Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Allergan SWOT Analysis
Table 39. Allergan Hidradenitis Suppurativa Treatment Product and Solutions
Table 40. Allergan Hidradenitis Suppurativa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. AbbVie Corporate Information, Location and Competitors
Table 42. AbbVie Hidradenitis Suppurativa Treatment Major Business
Table 43. AbbVie Hidradenitis Suppurativa Treatment Total Revenue (USD Million) (2017-2018)
Table 44. AbbVie SWOT Analysis
Table 45. AbbVie Hidradenitis Suppurativa Treatment Product and Solutions
Table 46. AbbVie Hidradenitis Suppurativa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Hidradenitis Suppurativa Treatment Revenue (Million USD) by Players (2015-2020)
Table 48. Global Hidradenitis Suppurativa Treatment Revenue Share by Players (2015-2020)
Table 49. Global Hidradenitis Suppurativa Treatment Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Regions (2015-2020)
Table 51. North America Hidradenitis Suppurativa Treatment Revenue by Countries (2015-2020)
Table 52. North America Hidradenitis Suppurativa Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Europe Hidradenitis Suppurativa Treatment Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Hidradenitis Suppurativa Treatment Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Hidradenitis Suppurativa Treatment Revenue by Countries (2015-2020)
Table 56. South America Hidradenitis Suppurativa Treatment Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Hidradenitis Suppurativa Treatment Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Hidradenitis Suppurativa Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Global Hidradenitis Suppurativa Treatment Revenue (Million USD) by Type (2015-2020)
Table 60. Global Hidradenitis Suppurativa Treatment Revenue Share by Type (2015-2020)
Table 61. Global Hidradenitis Suppurativa Treatment Revenue Forecast by Type (2021-2025)
Table 62. Global Hidradenitis Suppurativa Treatment Revenue by Application (2015-2020)
Table 63. Global Hidradenitis Suppurativa Treatment Revenue Share by Application (2015-2020)
Table 64. Global Hidradenitis Suppurativa Treatment Revenue Forecast by Application (2021-2025)
Table 65. Global Hidradenitis Suppurativa Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hidradenitis Suppurativa Treatment Picture
Figure 2. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Type in 2019
Figure 3. Medications Picture
Figure 4. Surgery Picture
Figure 5. Others Picture
Figure 6. Hidradenitis Suppurativa Treatment Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Others Picture
Figure 10. Global Hidradenitis Suppurativa Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Hidradenitis Suppurativa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Hidradenitis Suppurativa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Hidradenitis Suppurativa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Hidradenitis Suppurativa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Hidradenitis Suppurativa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Hidradenitis Suppurativa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Hidradenitis Suppurativa Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Hidradenitis Suppurativa Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Hidradenitis Suppurativa Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Hidradenitis Suppurativa Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Hidradenitis Suppurativa Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Hidradenitis Suppurativa Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Hidradenitis Suppurativa Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Hidradenitis Suppurativa Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Hidradenitis Suppurativa Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Hidradenitis Suppurativa Treatment Revenue Market Share by Countries in 2019
Figure 43. China Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Hidradenitis Suppurativa Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Hidradenitis Suppurativa Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Hidradenitis Suppurativa Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Hidradenitis Suppurativa Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Hidradenitis Suppurativa Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Hidradenitis Suppurativa Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Hidradenitis Suppurativa Treatment Revenue Share by Type in 2019
Figure 60. Global Hidradenitis Suppurativa Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Medications Revenue Growth Rate (2015-2020)
Figure 62. Global Surgery Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Hidradenitis Suppurativa Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Hidradenitis Suppurativa Treatment Revenue Share by Application in 2019
Figure 66. Global Hidradenitis Suppurativa Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Hidradenitis Suppurativa Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Hidradenitis Suppurativa Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Hidradenitis Suppurativa Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Hidradenitis Suppurativa Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

以下、関連資料のご紹介
  • クラッベ病治療の世界市場 2020年：企業別、地域別、種類・用途別
    Global Krabbe Disease Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    D005-00562 2020年5月29日 106Pages
    本調査レポートでは、クラッベ病治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。クラッベ病治療の種類別市場規模（抗けいれん薬、筋弛緩薬、HSCT、その他）、用途別市場規模（病院、ASC）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリ...
  • 結節性痒疹治療の世界市場 2020年：企業別、地域別、種類・用途別
    Global Prurigo Nodularis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    D005-00842 2020年5月29日 107Pages
    本調査レポートでは、結節性痒疹治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。結節性痒疹治療の種類別市場規模（カプサイシンクリーム、抗ヒスタミン剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南...
  • 変形性関節症治療の世界市場 2020年：企業別、地域別、種類・用途別
    Global Osteoarthritis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    D005-00783 2020年5月29日 101Pages
    本調査レポートでは、変形性関節症治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。変形性関節症治療の種類別市場規模（薬物、補助器具）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリ...
  • 多発性骨髄腫治療の世界市場 2020年：企業別、地域別、種類・用途別
    Global Multiple Myeloma Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    D005-00709 2020年5月29日 108Pages
    本調査レポートでは、多発性骨髄腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。多発性骨髄腫治療の種類別市場規模（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストン脱アセチル化酵素（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別市場規模（病院、クリニック、がん治療・リ...
  • 糖尿病性神経障害治療の世界市場 2020年：企業別、地域別、種類・用途別
    Global Diabetic Neuropathy Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    D005-00282 2020年5月29日 101Pages
    本調査レポートでは、糖尿病性神経障害治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。糖尿病性神経障害治療の種類別市場規模（末梢神経障害、自律神経障害、近位神経障害、限局性神経障害）、用途別市場規模（病院、クリニック、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国...
  • 脳動脈瘤治療の世界市場 2020年：企業別、地域別、種類・用途別
    Global Brain Aneurysm Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    D005-00138 2020年5月29日 106Pages
    本調査レポートでは、脳動脈瘤治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。脳動脈瘤治療の種類別市場規模（手術、薬、状態）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別...
  • 早期分娩治療の世界市場 2020年：企業別、地域別、種類・用途別
    Global Preterm Labor Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    D005-00829 2020年5月29日 109Pages
    本調査レポートでは、早期分娩治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。早期分娩治療の種類別市場規模（子宮収縮抑制薬、ベータ–ミメティック、カルシウムチャネルブロッカー、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質）、用途別市場規模（病院、小児科及び新生児クリ...
  • 結核治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別
    Global Tuberculosis Treatment Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    D005-15968 2020年5月26日 100Pages
    本調査レポートでは、結核治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。結核治療薬の種類別市場規模（アクティブTB、潜在TB）、用途別市場規模（病院、クリニック、ダーグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど...
  • 前立腺がん治療の世界市場 2020年：企業別、地域別、種類・用途別
    Global Prostate Cancer Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    D005-00839 2020年5月29日 109Pages
    本調査レポートでは、前立腺がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。前立腺がん治療の種類別市場規模（生物学的療法、化学療法）、用途別市場規模（病院、研究機関、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカな...
  • 女性用ストレス尿失禁治療装置の世界市場 2020年：メーカー別、地域別、種類・用途別
    Global Female Stress Urinary Incontinence Treatment Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    D005-06434 2020年5月22日 106Pages
    本調査レポートでは、女性用ストレス尿失禁治療装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。女性用ストレス尿失禁治療装置の種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（婦人科クリニック、病院、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中...